RT Journal Article
SR Electronic
T1 Predicting prolonged mechanical ventilation after endovascular treatment for acute vertebrobasilar artery occlusion
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.12.05.23299562
DO 10.1101/2023.12.05.23299562
A1 Cai, Qiankun
A1 Hong, Minying
A1 Xu, Yingjie
A1 Zhang, Shuai
A1 Huang, Zhixin
A1 Xu, Pengfei
A1 Huang, Xianjun
A1 Liu, Shufen
A1 Huang, Zhengping
A1 Ye, Lichao
A1 Chen, Jixing
A1 Huang, Hongyu
A1 Zheng, Feng
A1 Sun, Wen
YR 2023
UL http://medrxiv.org/content/early/2023/12/07/2023.12.05.23299562.abstract
AB Background Patients with acute vertebrobasilar artery occlusion (VBAO) after endovascular treatment (EVT) frequently require mechanical ventilation (MV). This study aims to develop and validate a predictive score for prolonged mechanical ventilation (PMV) in patients with VBAO after EVT.Methods The derivation cohort prospectively recruited acute VBAO patients undergoing EVT from four comprehensive stroke centers (CSCs) in China. PMV was defined as continuous MV for ≥96 hours. Two multivariable logistic regressions were performed to predict predictive models based on whether adding radiographic results at follow-up. The performance of two models was evaluated for discrimination, calibration, and clinical utility. A validation cohort of 444 patients from acute Posterior circulation ischemic Stroke registry was enrolled to validate two models.Results The derivation cohort consisted of 498 patients from four CSCs, among whom 204 (41.0%) required PMV. Reperfusion status, National Institutes of Health Stroke Scale scores, collateral circulation status, history of atrial fibrillation, fasting blood glucose, circulation insufficiency, the presence of malignant cerebellar edema, and symptomatic intracranial hemorrhage at follow-up imaging were found to be independent predictors of PMV in multivariable logistic regression. These variables were combined to create the basic and radiographic PAIRS scores. The basic PAIRS and radiographic PAIRS scores demonstrated adequate discrimination in derivation cohort (C-index, 0.77 [95%CI 0.73 to 0.81] and 0.80 [95%CI 0.77 to 0.84]), as well as the validation cohort (C-index, 0.70 [95%CI 0.65 to 0.75] and 0.75 [95%CI 0.70 to 0.80]), and had well-fitted calibration plot for both cohorts. Decision curve analysis showed that both PAIRS scores had satisfied net benefit in predicting PMV across various thresholds.Conclusions The PAIRS scores provide adequate accurate predictions of PMV in VBAO patients after EVT. These findings can assist patient families and caregivers in better understanding the treatment trajectory.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialhttp://www.chictr.org.cn/; unique identifier: ChiCTR2000033211Funding StatementThis work was supported by Startup Fund for scientific research of Fujian Medical University (No XJ2021014001), Science and Technology Program of Guangzhou (No 202201020359), Key Research and Development Plan Projects of Anhui Province (No 202104j07020049).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by ethics committee of USTC: No 2020-40; Guangdong Second Provincial General Hospital: No 2020-KY-KZ-100-03; the Second Affiliated Hospital of Fujian medical University: No 2020-339; The Affiliated hospital of Yangzhou University: No 2020-153.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the finds of this study are available from the corresponding author on reasonable request.